[PDF] Pharmacotherapy for allergic rhinitis | Semantic Scholar (2025)

Other pharmacotherapy options and alternative treatment methods in the treatment of allergic rhinitis are described based on “Allergic Rhinitis and its Impact on Asthma (ARIA)” guidelines and current literature.

Recognition of triggers and management strategies to correctly use 'relief' therapies such as topical nasal decongestants is the key to successful management.

The findings of efficacy and safety from these trials for the different preparations appear to be promising, and have encouraged an increasing number of studies to search for new medical herbs or their combinations for allergic rhinitis therapy.

The aim of this review is to provide an overview of all aspects of corticosteroid treatment including mode of application, way of action, potency, bioavailability, side effects, and aspects regarding the pediatric population.

The study demonstrated the effectiveness and cost efficiency of budesonide medicines for treating AR in children with BA, resulting in significant cost savings during the first treatment session.

The paper demonstrates the efficacy and safety of topical corticosteroids for use in clinical practice and warns that for best result intranasal cortICosteroids should be used at first signs of allergic rhinitis onset.

Management includes medication, avoidance of exposure to environmental allergens and when appropriate, measures to help with associated asthma and sinusitis, and Psychological interventions can also help in the management of AR.

The range of modern homeopathic remedies for the prevention and treatment of AR on the pharmaceutical market of Ukraine is mainly represented by drugs of foreign production and the assortment does not meet the needs of consumers.

...

...

A step-up/step-down approach to AR pharmacotherapy based on patient response may hold the potential for optimal control of AR symptoms while minimizing side effects and cost of treatment.

Intranasal cromolyn has an excellent safety record, is available as an over-the-counter medication, and has been proved to be efficacious in patients with allergic rhinitis, which is associated with impaired occupational function and performance in school and decreased quality of life.

Agents with broad therapeutic windows, based on both efficacy and safety, are expected to be more favorable; this therapeutic window should be understood by the primary care physician when prescribing a medication.

The ARIA guidelines were recently updated and recommended that the presence of asthma must be considered in all patients with rhinitis, and that in planning treatment, both should be considered together in terms of efficacy and safety.

The results of this trial demonstrate that azelastine nasal solution provides an alternative to oral medication in the treatment of SAR and its rapid onset and prolonged duration of action in relieving rhinitis symptoms and advantages over currently marketed topical treatments make it a good choice for Treatment of SAR.

Oral histamine H1-receptor antagonists (H1 antihistamines) are one of the most commonly prescribed medications for the treatment of AR and it is important to know the pharmacology, such as administration interval, onset of action, metabolism and conditions that require administration adjustments.

...

...